Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 1
2019 2
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation.
El Malki K, Wehling P, Alt F, Sandhoff R, Zahnreich S, Ustjanzew A, Wilzius C, Brockmann MA, Wingerter A, Russo A, Beck O, Sommer C, Ottenhausen M, Frauenknecht KBM, Paret C, Faber J. El Malki K, et al. Among authors: alt f. Int J Mol Sci. 2023 Jun 8;24(12):9905. doi: 10.3390/ijms24129905. Int J Mol Sci. 2023. PMID: 37373053 Free PMC article.
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.
Beck O, Paret C, Russo A, Burhenne J, Fresnais M, Steimel K, Seidmann L, Wagner DC, Vewinger N, Lehmann N, Sprang M, Backes N, Roth L, Neu MA, Wingerter A, Henninger N, Malki KE, Otto H, Alt F, Desuki A, Kindler T, Faber J. Beck O, et al. Among authors: alt f. Cancers (Basel). 2020 Mar 26;12(4):793. doi: 10.3390/cancers12040793. Cancers (Basel). 2020. PMID: 32224911 Free PMC article.
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.
Paret C, Lehmann N, Bender H, Sprang M, Sommer CJ, Cana D, Seidmann L, Wingerter A, Neu MA, El Malki K, Alt F, Roth L, Marini F, Ottenhausen M, Glaser M, Knuf M, Russo A, Faber J. Paret C, et al. Among authors: alt f. Cancers (Basel). 2021 Nov 21;13(22):5838. doi: 10.3390/cancers13225838. Cancers (Basel). 2021. PMID: 34830991 Free PMC article.
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.
Russo A, Paret C, Alt F, Burhenne J, Fresnais M, Wagner W, Glaser M, Bender H, Huprich S, Harter PN, Filipski K, Lehmann N, Backes N, Roth L, Seidmann L, Sommer C, Brockmann MA, Pietsch T, Neu MA, Wingerter A, Faber J. Russo A, et al. Among authors: alt f. Int J Mol Sci. 2019 Aug 30;20(17):4267. doi: 10.3390/ijms20174267. Int J Mol Sci. 2019. PMID: 31480400 Free PMC article.
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.
Vewinger N, Huprich S, Seidmann L, Russo A, Alt F, Bender H, Sommer C, Samuel D, Lehmann N, Backes N, Roth L, Harter PN, Filipski K, Faber J, Paret C. Vewinger N, et al. Among authors: alt f. Int J Mol Sci. 2019 Jun 21;20(12):3027. doi: 10.3390/ijms20123027. Int J Mol Sci. 2019. PMID: 31234291 Free PMC article.
Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
Paret C, Russo A, Otto H, Mayer A, Zahnreich S, Wagner W, Samuel D, Scharnhorst D, Solomon DA, Dhall G, Wong K, Bender H, Alt F, Wingerter A, Neu MA, Beck O, Prawitt D, Eder S, Henninger N, El Malki K, Lehmann N, Backes N, Roth L, Seidmann L, Sommer C, Brockmann MA, Staatz G, Schmidberger H, Faber J. Paret C, et al. Among authors: alt f. Oncotarget. 2017 Dec 11;8(69):114210-114225. doi: 10.18632/oncotarget.23174. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371980 Free PMC article.
11 results